• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

AAIC: First Clinical Data from an RNAi Therapeutic for Alzheimer’s Continue to Impress

cafead

Administrator
Staff member
  • cafead   Jul 18, 2023 at 12:12: PM
via RNAi therapeutics made clinical headway in Alzheimer’s disease Monday, as Alnylam announced data from a Phase I study of ALN-APP showing the therapy reduced levels of an Alzheimer’s-linked protein by around two-thirds.

article source